Abstract
As we learn more about the anticonvulsant drugs, we find it easier to understand the apparent failure of these agents to control epilepsy in about one of four patients and also the apparent toxicity of usual dosages in certain patients. Most of the new information in this area concerns the drugs diphenylhydantoin and phenobarbital. A practical approach to management of epileptics is outlined.